Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:47 AM EDT

Mosaic ImmunoEngineering (CPMV) Receivables (2011)

Updated

Mosaic ImmunoEngineering's Receivables came in at $113,786 for Q2 2012, up 314.4% from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Receivables (2011) Analysis & Trends

At the end of FY2011, Mosaic ImmunoEngineering's Receivables was $316,810.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,133.90 Bn 1,102.48 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 616.46 Bn 534.99 Bn 17.26 Bn 19.05 Bn
3 AbbVie 501.26 Bn 474.37 Bn 12.70 Bn 13.82 Bn
4 Merck 367.00 Bn 321.38 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 15.68 Bn
7 Amgen 235.82 Bn 191.22 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.63 Bn 164.82 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn 12.49 Bn
10 Mosaic ImmunoEngineering 441,423.27 352,385.27 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 113,786.00
Aug 31, 2011 27,456.00
May 31, 2011 316,810.00
API Access

Mosaic ImmunoEngineering Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=CPMV&period=max&api_key=YOUR_API_KEY